Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy

Lancet. 1983 May 28;1(8335):1175-9. doi: 10.1016/s0140-6736(83)92462-5.

Abstract

The effect of early aggressive antihypertensive treatment on kidney function in diabetic nephropathy was studied prospectively in ten insulin-dependent diabetics (mean age 29 years). During the mean pretreatment period of 29 (range 23-38) months the glomerular filtration rate (GFR) decreased significantly and the urinary albumin excretion rate and arterial blood pressure rose significantly. During the 39 month (range 28-48) period of antihypertensive treatment with metoprolol, hydralazine, and frusemide (furosemide) or thiazide, arterial blood pressure fell from 144/97 mm Hg (mean of all pretreatment values) to 128/84 mm Hg (mean of all post-treatment values), urinary albumin excretion from 977 micrograms/min to 433 micrograms/min, and GFR from 80 to 62 ml/min/1 . 73 m2. The rate of decline in GFR decreased from 0.91 ml/min/month before treatment to 0.39 ml/min/month (range 0.08 to 0.68 ml/min/month) during treatment.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antihypertensive Agents / pharmacology
  • Antihypertensive Agents / therapeutic use*
  • Blood Pressure / drug effects
  • Diabetes Mellitus / drug therapy
  • Diabetes Mellitus / physiopathology
  • Diabetic Nephropathies / drug therapy
  • Diabetic Nephropathies / physiopathology*
  • Diuretics / pharmacology
  • Female
  • Glomerular Filtration Rate / drug effects
  • Humans
  • Hypertension / drug therapy*
  • Hypertension / physiopathology
  • Kidney / blood supply
  • Kidney / drug effects*
  • Kidney / physiopathology
  • Kidney Failure, Chronic / prevention & control
  • Male
  • Metoprolol / pharmacology
  • Metoprolol / therapeutic use
  • Microcirculation / drug effects
  • Prospective Studies
  • Time Factors

Substances

  • Antihypertensive Agents
  • Diuretics
  • Metoprolol